Natsuko Okita Selected Research

regorafenib

1/2022

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Natsuko Okita Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 01/2008
13	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 05/2012
12	Stomach Neoplasms (Stomach Cancer) 01/2024 - 02/2009
6	Esophageal Squamous Cell Carcinoma 03/2024 - 12/2014
6	Disease Progression 03/2024 - 01/2016
6	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2012
4	Neuroendocrine Carcinoma 04/2024 - 09/2014
4	Adenocarcinoma 03/2024 - 01/2008
4	Carcinoma (Carcinomatosis) 11/2020 - 01/2016
3	Esophageal Neoplasms (Esophageal Cancer) 03/2024 - 12/2014
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2020
2	Anorexia 01/2020 - 08/2010
2	Diarrhea 10/2019 - 08/2010
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 01/2018
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 09/2014
1	Lymphatic Metastasis 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Glioma (Gliomas) 03/2024
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 03/2024
1	Thyroid Neoplasms (Thyroid Cancer) 03/2024
1	Microsatellite Instability 10/2023
1	Turcot syndrome 10/2023
1	Sarcoma (Soft Tissue Sarcoma) 09/2023
1	Emergence Delirium 08/2023
1	Delirium 08/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Lung Neoplasms (Lung Cancer) 10/2019
1	Hyperglycemia 10/2019
1	Colitis 10/2019
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2019
1	Melanoma (Melanoma, Malignant) 10/2019
1	Mucositis 10/2019
1	Esophagitis 10/2019
1	Hemorrhage 10/2019
1	Pharyngitis (Sore Throat) 10/2019
1	Sinonasal undifferentiated carcinoma 03/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2019
1	Rectal Neoplasms (Rectal Cancer) 05/2017
1	Peritoneal Neoplasms 01/2016

Drug/Important Bio-Agent (IBA)

9	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2008
9	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 05/2017
8	Irinotecan (Camptosar)FDA LinkGeneric 04/2024 - 01/2008
6	PlatinumIBA 04/2020 - 12/2014
5	NivolumabIBA 01/2024 - 01/2019
4	Bevacizumab (Avastin)FDA Link 01/2022 - 05/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 04/2020 - 12/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 05/2017
3	Docetaxel (Taxotere)FDA Link 03/2024 - 12/2014
3	Immune Checkpoint InhibitorsIBA 10/2023 - 10/2019
3	ErbB Receptors (EGF Receptor)IBA 09/2023 - 05/2015
3	RamucirumabIBA 04/2020 - 07/2017
2	Etoposide (VP 16)FDA LinkGeneric 04/2024 - 01/2020
2	Leucovorin (Folinic Acid)FDA Link 03/2024 - 05/2017
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2012
2	trifluridine tipiracil drug combinationIBA 01/2022 - 01/2020
2	Panitumumab (Vectibix)FDA Link 01/2021 - 07/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2009
2	Taxoids (Taxanes)IBA 07/2017 - 12/2014
1	capmatinibIBA 04/2024
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	dabrafenibIBA 03/2024
1	trametinibIBA 03/2024
1	CarbohydratesIBA 09/2023
1	AntigensIBA 09/2023
1	Carcinoembryonic AntigenIBA 09/2023
1	Circulating Tumor DNAIBA 09/2023
1	ramelteon (Rozerem)FDA Link 08/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2022
1	regorafenibIBA 01/2022
1	AntioxidantsIBA 02/2020
1	Proteins (Proteins, Gene)FDA Link 02/2020
1	SolventsIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	AlbuminsIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	lenvatinibIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Monoclonal AntibodiesIBA 02/2018
1	Everolimus FDA Link 01/2018
1	Thyroid Nuclear Factor 1IBA 05/2017
1	Cetuximab (Erbitux)FDA Link 07/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	EpiregulinIBA 01/2016

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 04/2024 - 01/2008
8	Therapeutics 04/2024 - 12/2014
4	Chemoradiotherapy 03/2024 - 03/2019
4	Genomic Medicine 01/2024 - 02/2021
3	Aftercare (After-Treatment) 01/2024 - 02/2022
2	Gastrectomy 08/2023 - 02/2009
2	Adjuvant Chemotherapy 02/2020 - 05/2017
2	Radiotherapy 01/2020 - 03/2019
1	Precision Medicine 12/2023
1	Molecular Targeted Therapy 08/2022
1	Salvage Therapy 01/2021
1	Induction Chemotherapy 03/2019
1	Immunotherapy 01/2019